T-cell large granular lymphocytic leukemia: treatment experience with fludarabine
OBJECTIVES: The aim of this retrospective study was to investigate the results of T-cell large granular lymphocytic leukemia treatment with fludarabine by assessing the complete hematologic response, the complete molecular response, progression-free survival, and overall survival. METHODS: We evalua...
Main Authors: | Renata Oliveira Costa, Marcelo Bellesso, Dalton Alencar Fischer Chamone, Milton Artur Ruiz, Abrahão Elias Hallack Neto, Vera Lucia Aldred, Juliana Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2012-07-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000700007 |
Similar Items
-
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01) -
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01) -
First research of use Vero-Fludarabine in chronic lymphocytic leukemia and non-hodgkins lymphoma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Long-term survival after fludarabine, cyclophosphamide, and rituximab treatment in previously untreated chronic lymphocytic leukemia patients
by: Shokhan Mohammad Mustafa, et al.
Published: (2021-01-01) -
Blockade of CD73 Increases the Cytotoxic Effects of Fludarabine in Chronic Lymphocytic Leukemia
by: Mohammad Sadeghi, et al.
Published: (2022-12-01)